Serveur d'exploration sur la COVID en France

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

[Tracing the origins of SARS-COV-2 in coronavirus phylogenies].

Identifieur interne : 000068 ( Main/Exploration ); précédent : 000067; suivant : 000069

[Tracing the origins of SARS-COV-2 in coronavirus phylogenies].

Auteurs : Erwan Sallard [France] ; José Halloy [France] ; Didier Casane [France] ; Jacques Van Helden [France] ; Étienne Decroly [France]

Source :

RBID : pubmed:32773024

Descripteurs français

English descriptors

Abstract

SARS-CoV-2 is a new human coronavirus (CoV), which emerged in People's Republic of China at the end of 2019 and is responsible for the global Covid-19 pandemic that caused more than 540 000 deaths in six months. Understanding the origin of this virus is an important issue and it is necessary to determine the mechanisms of its dissemination in order to be able to contain new epidemics. Based on phylogenetic inferences, sequence analysis and structure-function relationships of coronavirus proteins, informed by the knowledge currently available, we discuss the different scenarios evoked to account for the origin - natural or synthetic - of the virus. On the basis of currently available data, it is impossible to determine whether SARS-CoV-2 is the result of a natural zoonotic emergence or an accidental escape from experimental strains. Regardless of its origin, the study of the evolution of the molecular mechanisms involved in the emergence of this pandemic virus is essential to develop therapeutic and vaccine strategies.

Title

Retrouver les origines du SARS-CoV-2 dans les phylogénies de coronavirus.

Abstract

Le SARS-CoV-2 est un nouveau coronavirus (CoV) humain. Il a émergé en Chine fin 2019 et est responsable de la pandémie mondiale de Covid-19 qui a causé plus de 540 000 décès en six mois. La compréhension de l’origine de ce virus est une question importante et il est nécessaire de déterminer les mécanismes de sa dissémination afin de pouvoir se prémunir de nouvelles épidémies. En nous fondant sur des inférences phylogénétiques, l’analyse des séquences et les relations structure-fonction des protéines de coronavirus, éclairées par les connaissances actuellement disponibles, nous discutons les différents scénarios évoqués pour rendre compte de l’origine - naturelle ou synthétique - du virus.


DOI: 10.1051/medsci/2020123
PubMed: 32773024


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">[Tracing the origins of SARS-COV-2 in coronavirus phylogenies].</title>
<author>
<name sortKey="Sallard, Erwan" sort="Sallard, Erwan" uniqKey="Sallard E" first="Erwan" last="Sallard">Erwan Sallard</name>
<affiliation wicri:level="3">
<nlm:affiliation>École Normale Supérieure de Paris, 45 rue d'Ulm, 75005 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>École Normale Supérieure de Paris, 45 rue d'Ulm, 75005 Paris</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Halloy, Jose" sort="Halloy, Jose" uniqKey="Halloy J" first="José" last="Halloy">José Halloy</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université de Paris, CNRS, LIED UMR 8236, 85 bd Saint-Germain, 75006 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Paris, CNRS, LIED UMR 8236, 85 bd Saint-Germain, 75006 Paris</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Casane, Didier" sort="Casane, Didier" uniqKey="Casane D" first="Didier" last="Casane">Didier Casane</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université Paris-Saclay, CNRS, IRD, UMR Évolution, Génomes, Comportement et Écologie, 91198, Gif-sur-Yvette, France - Université de Paris, UFR Sciences du Vivant, F-75013 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris-Saclay, CNRS, IRD, UMR Évolution, Génomes, Comportement et Écologie, 91198, Gif-sur-Yvette, France - Université de Paris, UFR Sciences du Vivant, F-75013 Paris</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Van Helden, Jacques" sort="Van Helden, Jacques" uniqKey="Van Helden J" first="Jacques" last="Van Helden">Jacques Van Helden</name>
<affiliation wicri:level="3">
<nlm:affiliation>CNRS, Institut Français de Bioinformatique, IFB-core, UMS 3601, Évry, France - Aix-Marseille Univ, Inserm, laboratoire Theory and approaches of genome complexity (TAGC), Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>CNRS, Institut Français de Bioinformatique, IFB-core, UMS 3601, Évry, France - Aix-Marseille Univ, Inserm, laboratoire Theory and approaches of genome complexity (TAGC), Marseille</wicri:regionArea>
<placeName>
<region type="region">Provence-Alpes-Côte d'Azur</region>
<region type="old region">Provence-Alpes-Côte d'Azur</region>
<settlement type="city">Marseille</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Decroly, Etienne" sort="Decroly, Etienne" uniqKey="Decroly E" first="Étienne" last="Decroly">Étienne Decroly</name>
<affiliation wicri:level="3">
<nlm:affiliation>AFMB, CNRS, Aix-Marseille Univ, UMR 7257, Case 925, 163 avenue de Luminy, 13288 Marseille Cedex 09, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>AFMB, CNRS, Aix-Marseille Univ, UMR 7257, Case 925, 163 avenue de Luminy, 13288 Marseille Cedex 09</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Provence-Alpes-Côte d'Azur</region>
<settlement type="city">Marseille</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020 Aug-Sep</date>
<idno type="RBID">pubmed:32773024</idno>
<idno type="pmid">32773024</idno>
<idno type="doi">10.1051/medsci/2020123</idno>
<idno type="wicri:Area/Main/Corpus">000667</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000667</idno>
<idno type="wicri:Area/Main/Curation">000667</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000667</idno>
<idno type="wicri:Area/Main/Exploration">000667</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">[Tracing the origins of SARS-COV-2 in coronavirus phylogenies].</title>
<author>
<name sortKey="Sallard, Erwan" sort="Sallard, Erwan" uniqKey="Sallard E" first="Erwan" last="Sallard">Erwan Sallard</name>
<affiliation wicri:level="3">
<nlm:affiliation>École Normale Supérieure de Paris, 45 rue d'Ulm, 75005 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>École Normale Supérieure de Paris, 45 rue d'Ulm, 75005 Paris</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Halloy, Jose" sort="Halloy, Jose" uniqKey="Halloy J" first="José" last="Halloy">José Halloy</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université de Paris, CNRS, LIED UMR 8236, 85 bd Saint-Germain, 75006 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université de Paris, CNRS, LIED UMR 8236, 85 bd Saint-Germain, 75006 Paris</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Casane, Didier" sort="Casane, Didier" uniqKey="Casane D" first="Didier" last="Casane">Didier Casane</name>
<affiliation wicri:level="3">
<nlm:affiliation>Université Paris-Saclay, CNRS, IRD, UMR Évolution, Génomes, Comportement et Écologie, 91198, Gif-sur-Yvette, France - Université de Paris, UFR Sciences du Vivant, F-75013 Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris-Saclay, CNRS, IRD, UMR Évolution, Génomes, Comportement et Écologie, 91198, Gif-sur-Yvette, France - Université de Paris, UFR Sciences du Vivant, F-75013 Paris</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Van Helden, Jacques" sort="Van Helden, Jacques" uniqKey="Van Helden J" first="Jacques" last="Van Helden">Jacques Van Helden</name>
<affiliation wicri:level="3">
<nlm:affiliation>CNRS, Institut Français de Bioinformatique, IFB-core, UMS 3601, Évry, France - Aix-Marseille Univ, Inserm, laboratoire Theory and approaches of genome complexity (TAGC), Marseille, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>CNRS, Institut Français de Bioinformatique, IFB-core, UMS 3601, Évry, France - Aix-Marseille Univ, Inserm, laboratoire Theory and approaches of genome complexity (TAGC), Marseille</wicri:regionArea>
<placeName>
<region type="region">Provence-Alpes-Côte d'Azur</region>
<region type="old region">Provence-Alpes-Côte d'Azur</region>
<settlement type="city">Marseille</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Decroly, Etienne" sort="Decroly, Etienne" uniqKey="Decroly E" first="Étienne" last="Decroly">Étienne Decroly</name>
<affiliation wicri:level="3">
<nlm:affiliation>AFMB, CNRS, Aix-Marseille Univ, UMR 7257, Case 925, 163 avenue de Luminy, 13288 Marseille Cedex 09, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>AFMB, CNRS, Aix-Marseille Univ, UMR 7257, Case 925, 163 avenue de Luminy, 13288 Marseille Cedex 09</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Provence-Alpes-Côte d'Azur</region>
<settlement type="city">Marseille</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Medecine sciences : M/S</title>
<idno type="eISSN">1958-5381</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amino Acid Sequence (MeSH)</term>
<term>Animals (MeSH)</term>
<term>Betacoronavirus (classification)</term>
<term>Betacoronavirus (genetics)</term>
<term>Betacoronavirus (isolation & purification)</term>
<term>Biohazard Release (MeSH)</term>
<term>China (epidemiology)</term>
<term>Communicable Diseases, Emerging (virology)</term>
<term>Coronaviridae Infections (transmission)</term>
<term>Coronaviridae Infections (veterinary)</term>
<term>Coronaviridae Infections (virology)</term>
<term>Coronavirus (classification)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (transmission)</term>
<term>Coronavirus Infections (virology)</term>
<term>Disease Reservoirs (MeSH)</term>
<term>Evolution, Molecular (MeSH)</term>
<term>Gain of Function Mutation (MeSH)</term>
<term>Genome, Viral (MeSH)</term>
<term>HIV (genetics)</term>
<term>Host Specificity (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Mammals (virology)</term>
<term>Pandemics (MeSH)</term>
<term>Phylogeny (MeSH)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (transmission)</term>
<term>Pneumonia, Viral (virology)</term>
<term>RNA, Viral (genetics)</term>
<term>Reassortant Viruses (genetics)</term>
<term>Sequence Alignment (MeSH)</term>
<term>Sequence Homology, Amino Acid (MeSH)</term>
<term>Spike Glycoprotein, Coronavirus (chemistry)</term>
<term>Spike Glycoprotein, Coronavirus (genetics)</term>
<term>Spike Glycoprotein, Coronavirus (physiology)</term>
<term>Zoonoses (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>ARN viral (génétique)</term>
<term>Alignement de séquences (MeSH)</term>
<term>Animaux (MeSH)</term>
<term>Betacoronavirus (classification)</term>
<term>Betacoronavirus (génétique)</term>
<term>Betacoronavirus (isolement et purification)</term>
<term>Chine (épidémiologie)</term>
<term>Coronavirus (classification)</term>
<term>Glycoprotéine de spicule des coronavirus (composition chimique)</term>
<term>Glycoprotéine de spicule des coronavirus (génétique)</term>
<term>Glycoprotéine de spicule des coronavirus (physiologie)</term>
<term>Génome viral (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections à Coronaviridae (médecine vétérinaire)</term>
<term>Infections à Coronaviridae (transmission)</term>
<term>Infections à Coronaviridae (virologie)</term>
<term>Infections à coronavirus (transmission)</term>
<term>Infections à coronavirus (virologie)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Maladies transmissibles émergentes (virologie)</term>
<term>Mammifères (virologie)</term>
<term>Mutation gain de fonction (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Phylogenèse (MeSH)</term>
<term>Pneumopathie virale (transmission)</term>
<term>Pneumopathie virale (virologie)</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>Rejet de substances biologiques dangereuses (MeSH)</term>
<term>Réservoirs de maladies (MeSH)</term>
<term>Similitude de séquences d'acides aminés (MeSH)</term>
<term>Spécificité d'hôte (MeSH)</term>
<term>Séquence d'acides aminés (MeSH)</term>
<term>VIH (Virus de l'Immunodéficience Humaine) (génétique)</term>
<term>Virus recombinants (génétique)</term>
<term>Zoonoses (MeSH)</term>
<term>Évolution moléculaire (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Spike Glycoprotein, Coronavirus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>RNA, Viral</term>
<term>Spike Glycoprotein, Coronavirus</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>China</term>
</keywords>
<keywords scheme="MESH" qualifier="classification" xml:lang="en">
<term>Betacoronavirus</term>
<term>Coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="composition chimique" xml:lang="fr">
<term>Betacoronavirus</term>
<term>Coronavirus</term>
<term>Glycoprotéine de spicule des coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Betacoronavirus</term>
<term>HIV</term>
<term>Reassortant Viruses</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>ARN viral</term>
<term>Betacoronavirus</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>VIH (Virus de l'Immunodéficience Humaine)</term>
<term>Virus recombinants</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en">
<term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr">
<term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="médecine vétérinaire" xml:lang="fr">
<term>Infections à Coronaviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Glycoprotéine de spicule des coronavirus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en">
<term>Spike Glycoprotein, Coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en">
<term>Coronaviridae Infections</term>
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="veterinary" xml:lang="en">
<term>Coronaviridae Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Infections à Coronaviridae</term>
<term>Infections à coronavirus</term>
<term>Maladies transmissibles émergentes</term>
<term>Mammifères</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Communicable Diseases, Emerging</term>
<term>Coronaviridae Infections</term>
<term>Coronavirus Infections</term>
<term>Mammals</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Chine</term>
<term>Infections à Coronaviridae</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Biohazard Release</term>
<term>Disease Reservoirs</term>
<term>Evolution, Molecular</term>
<term>Gain of Function Mutation</term>
<term>Genome, Viral</term>
<term>Host Specificity</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Phylogeny</term>
<term>Sequence Alignment</term>
<term>Sequence Homology, Amino Acid</term>
<term>Zoonoses</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Alignement de séquences</term>
<term>Animaux</term>
<term>Génome viral</term>
<term>Humains</term>
<term>Mutation gain de fonction</term>
<term>Pandémies</term>
<term>Phylogenèse</term>
<term>Rejet de substances biologiques dangereuses</term>
<term>Réservoirs de maladies</term>
<term>Similitude de séquences d'acides aminés</term>
<term>Spécificité d'hôte</term>
<term>Séquence d'acides aminés</term>
<term>Zoonoses</term>
<term>Évolution moléculaire</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>République populaire de Chine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">SARS-CoV-2 is a new human coronavirus (CoV), which emerged in People's Republic of China at the end of 2019 and is responsible for the global Covid-19 pandemic that caused more than 540 000 deaths in six months. Understanding the origin of this virus is an important issue and it is necessary to determine the mechanisms of its dissemination in order to be able to contain new epidemics. Based on phylogenetic inferences, sequence analysis and structure-function relationships of coronavirus proteins, informed by the knowledge currently available, we discuss the different scenarios evoked to account for the origin - natural or synthetic - of the virus. On the basis of currently available data, it is impossible to determine whether SARS-CoV-2 is the result of a natural zoonotic emergence or an accidental escape from experimental strains. Regardless of its origin, the study of the evolution of the molecular mechanisms involved in the emergence of this pandemic virus is essential to develop therapeutic and vaccine strategies.</div>
<div type="abstract" xml:lang="fr">
<p>
<b>Title</b>
</p>
<p>Retrouver les origines du SARS-CoV-2 dans les phylogénies de coronavirus.</p>
</div>
<div type="abstract" xml:lang="fr">
<p>
<b>Abstract</b>
</p>
<p>Le SARS-CoV-2 est un nouveau coronavirus (CoV) humain. Il a émergé en Chine fin 2019 et est responsable de la pandémie mondiale de Covid-19 qui a causé plus de 540 000 décès en six mois. La compréhension de l’origine de ce virus est une question importante et il est nécessaire de déterminer les mécanismes de sa dissémination afin de pouvoir se prémunir de nouvelles épidémies. En nous fondant sur des inférences phylogénétiques, l’analyse des séquences et les relations structure-fonction des protéines de coronavirus, éclairées par les connaissances actuellement disponibles, nous discutons les différents scénarios évoqués pour rendre compte de l’origine - naturelle ou synthétique - du virus.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32773024</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>08</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>08</Month>
<Day>28</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1958-5381</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>36</Volume>
<Issue>8-9</Issue>
<PubDate>
<MedlineDate>2020 Aug-Sep</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Medecine sciences : M/S</Title>
<ISOAbbreviation>Med Sci (Paris)</ISOAbbreviation>
</Journal>
<ArticleTitle>[Tracing the origins of SARS-COV-2 in coronavirus phylogenies].</ArticleTitle>
<Pagination>
<MedlinePgn>783-796</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1051/medsci/2020123</ELocationID>
<Abstract>
<AbstractText>SARS-CoV-2 is a new human coronavirus (CoV), which emerged in People's Republic of China at the end of 2019 and is responsible for the global Covid-19 pandemic that caused more than 540 000 deaths in six months. Understanding the origin of this virus is an important issue and it is necessary to determine the mechanisms of its dissemination in order to be able to contain new epidemics. Based on phylogenetic inferences, sequence analysis and structure-function relationships of coronavirus proteins, informed by the knowledge currently available, we discuss the different scenarios evoked to account for the origin - natural or synthetic - of the virus. On the basis of currently available data, it is impossible to determine whether SARS-CoV-2 is the result of a natural zoonotic emergence or an accidental escape from experimental strains. Regardless of its origin, the study of the evolution of the molecular mechanisms involved in the emergence of this pandemic virus is essential to develop therapeutic and vaccine strategies.</AbstractText>
<CopyrightInformation>© 2020 médecine/sciences – Inserm.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sallard</LastName>
<ForeName>Erwan</ForeName>
<Initials>E</Initials>
<Identifier Source="ORCID">0000-0002-2324-3633</Identifier>
<AffiliationInfo>
<Affiliation>École Normale Supérieure de Paris, 45 rue d'Ulm, 75005 Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Halloy</LastName>
<ForeName>José</ForeName>
<Initials>J</Initials>
<Identifier Source="ORCID">0000-0003-1555-2484</Identifier>
<AffiliationInfo>
<Affiliation>Université de Paris, CNRS, LIED UMR 8236, 85 bd Saint-Germain, 75006 Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Casane</LastName>
<ForeName>Didier</ForeName>
<Initials>D</Initials>
<Identifier Source="ORCID">0000-0001-5463-1092</Identifier>
<AffiliationInfo>
<Affiliation>Université Paris-Saclay, CNRS, IRD, UMR Évolution, Génomes, Comportement et Écologie, 91198, Gif-sur-Yvette, France - Université de Paris, UFR Sciences du Vivant, F-75013 Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>van Helden</LastName>
<ForeName>Jacques</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>CNRS, Institut Français de Bioinformatique, IFB-core, UMS 3601, Évry, France - Aix-Marseille Univ, Inserm, laboratoire Theory and approaches of genome complexity (TAGC), Marseille, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Decroly</LastName>
<ForeName>Étienne</ForeName>
<Initials>É</Initials>
<AffiliationInfo>
<Affiliation>AFMB, CNRS, Aix-Marseille Univ, UMR 7257, Case 925, 163 avenue de Luminy, 13288 Marseille Cedex 09, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>fre</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Retrouver les origines du SARS-CoV-2 dans les phylogénies de coronavirus.</VernacularTitle>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>08</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>France</Country>
<MedlineTA>Med Sci (Paris)</MedlineTA>
<NlmUniqueID>8710980</NlmUniqueID>
<ISSNLinking>0767-0974</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055885" MajorTopicYN="N">Biohazard Release</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D021821" MajorTopicYN="N">Communicable Diseases, Emerging</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003333" MajorTopicYN="N">Coronaviridae Infections</DescriptorName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
<QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017934" MajorTopicYN="N">Coronavirus</DescriptorName>
<QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004197" MajorTopicYN="N">Disease Reservoirs</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019143" MajorTopicYN="Y">Evolution, Molecular</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000073659" MajorTopicYN="N">Gain of Function Mutation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016679" MajorTopicYN="N">Genome, Viral</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006678" MajorTopicYN="N">HIV</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058507" MajorTopicYN="N">Host Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008322" MajorTopicYN="N">Mammals</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010802" MajorTopicYN="Y">Phylogeny</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016865" MajorTopicYN="N">Reassortant Viruses</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016415" MajorTopicYN="N">Sequence Alignment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015047" MajorTopicYN="N">Zoonoses</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherAbstract Type="Publisher" Language="fre">
<AbstractText Label="Title" NlmCategory="UNASSIGNED">Retrouver les origines du SARS-CoV-2 dans les phylogénies de coronavirus.</AbstractText>
<AbstractText Label="Abstract" NlmCategory="UNASSIGNED">Le SARS-CoV-2 est un nouveau coronavirus (CoV) humain. Il a émergé en Chine fin 2019 et est responsable de la pandémie mondiale de Covid-19 qui a causé plus de 540 000 décès en six mois. La compréhension de l’origine de ce virus est une question importante et il est nécessaire de déterminer les mécanismes de sa dissémination afin de pouvoir se prémunir de nouvelles épidémies. En nous fondant sur des inférences phylogénétiques, l’analyse des séquences et les relations structure-fonction des protéines de coronavirus, éclairées par les connaissances actuellement disponibles, nous discutons les différents scénarios évoqués pour rendre compte de l’origine - naturelle ou synthétique - du virus.</AbstractText>
</OtherAbstract>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>8</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>8</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>8</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32773024</ArticleId>
<ArticleId IdType="doi">10.1051/medsci/2020123</ArticleId>
<ArticleId IdType="pii">msc200195</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Drosten C, Günther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003 ; 348 : 1967–1976.</Citation>
</Reference>
<Reference>
<Citation>Zaki AM, van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012 ; 367 : 1814–1820.</Citation>
</Reference>
<Reference>
<Citation>Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020 ; 395 : 565–574.</Citation>
</Reference>
<Reference>
<Citation>Menachery VD, Yount BL, Debbink K, et al. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nat Med 2015 ; 21 : 1508–1513.</Citation>
</Reference>
<Reference>
<Citation>Hu B, Zeng L-P, Yang X-L, et al. Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus. PLoS Pathog 2017 ; 13 : e1006698.</Citation>
</Reference>
<Reference>
<Citation>Luk HKH, Li X, Fung J, et al. Molecular epidemiology, evolution and phylogeny of SARS coronavirus. Infect. Genet Evol 2019 ; 71 : 21–30.</Citation>
</Reference>
<Reference>
<Citation>Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019 ; 17 : 181–192.</Citation>
</Reference>
<Reference>
<Citation>Song HD, Tu CC, Zhang GW, et al. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc Natl Acad Sci USA 2005 ; 102 : 2430–2435.</Citation>
</Reference>
<Reference>
<Citation>Sabir JSM, Lam TT-Y, Ahmed MMM, et al. Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia. Science 2016 ; 351 : 81–84.</Citation>
</Reference>
<Reference>
<Citation>Luis AD, Hayman DTS, O’Shea TJ, et al. A comparison of bats and rodents as reservoirs of zoonotic viruses: are bats special?. Proc Biol Sci 2013 ; 280 : 20122753.</Citation>
</Reference>
<Reference>
<Citation>Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579 : 270–3.</Citation>
</Reference>
<Reference>
<Citation>Ge XY, Wang N, Zhang W, et al. Coexistence of multiple coronaviruses in several bat colonies in an abandoned mineshaft. Virol Sin 2016 ; 31 : 31–40.</Citation>
</Reference>
<Reference>
<Citation>Zhou H, Chen X, Hu T, et al. A novel bat coronavirus closely related to SARS-CoV-2 contains natural insertions at the S1/S2 cleavage site of the spike protein. Curr Biol 2020; 30 : 2196–2203.e3.</Citation>
</Reference>
<Reference>
<Citation>Ferron F, Subissi L, Silveira De Morais AT, et al. Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA. Proc Natl Acad Sci USA 2018 ; 115 : E162–E171.</Citation>
</Reference>
<Reference>
<Citation>Casane D, Policarpo M, Laurenti P. Pourquoi le taux de mutation n’est-il jamais égal à zéro ?. Med Sci (Paris) 2019 ; 35 : 245–251.</Citation>
</Reference>
<Reference>
<Citation>Graham RL, Baric RS. Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission. J Virol 2010 ; 84 : 3134–3146.</Citation>
</Reference>
<Reference>
<Citation>Lam TTY, Shum MHH, Zhu HC, et al. Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins. Nature 2020. doi: 10.1038/s41586-020-2169-0.</Citation>
</Reference>
<Reference>
<Citation>Xiao K, Zhai J, Feng Y, et al. Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins. Nature 2020; 1–7.</Citation>
</Reference>
<Reference>
<Citation>Liu P, Jiang J-Z, Wan XF, et al. Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?. PLoS Pathog 2020 ; 16 : e1008421.</Citation>
</Reference>
<Reference>
<Citation>Zhang T, Wu Q, Zhang Z. Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak. Curr Biol 2020; 30 : 1346–1351.e2.</Citation>
</Reference>
<Reference>
<Citation>Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020 ; 395; 497–506.</Citation>
</Reference>
<Reference>
<Citation>Andersen KG, Rambaut A, Lipkin WI, et al. The proximal origin of SARS-CoV-2. Nat Med 2020; 26 : 450–52.</Citation>
</Reference>
<Reference>
<Citation>Cheng VCC, Lau SKP, Woo PCY, et al. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev 2007 ; 20 : 660–694.</Citation>
</Reference>
<Reference>
<Citation>Ziegler CGK, Allon SJ, Nyquist SK, et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell 2020; 181 : 1016–35.e19.</Citation>
</Reference>
<Reference>
<Citation>Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020; 181 : 271–80.e8.</Citation>
</Reference>
<Reference>
<Citation>Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020; 367 : 1260–3.</Citation>
</Reference>
<Reference>
<Citation>Walls AC, Park Y-J, Tortorici MA, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 2020; 181 : 281–92.e6.</Citation>
</Reference>
<Reference>
<Citation>Wang Q, Zhang Y, Wu L, et al. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell 2020; 181 : 894–904.e9.</Citation>
</Reference>
<Reference>
<Citation>Ni L, Ye F, Cheng M-L, et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity 2020; S1074–7613(20)30181–3.</Citation>
</Reference>
<Reference>
<Citation>Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol 2020; 5 : 562–9.</Citation>
</Reference>
<Reference>
<Citation>Yan R, Zhang Y, Li Y, et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 2020; 367 : 1444–8.</Citation>
</Reference>
<Reference>
<Citation>Russell CA, Fonville JM, Brown AEX, et al. The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science 2012 ; 336 : 1541–1547.</Citation>
</Reference>
<Reference>
<Citation>Imai M, Watanabe T, Hatta M, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 2012 ; 486 : 420–428.</Citation>
</Reference>
<Reference>
<Citation>Committee on Science T, Affairs P and G, Sciences B on L, et al. Official statements. National Academies Press (US), 2013.</Citation>
</Reference>
<Reference>
<Citation>Van Boeckel TP, Tildesley MJ, Linard C, et al. The Nosoi commute: a spatial perspective on the rise of BSL-4 laboratories in cities. arXiv:1312.3283 [q-bio] 2013.</Citation>
</Reference>
<Reference>
<Citation>Enserink M.. Singapore Lab Faulted in SARS Case. Science 2003 ; 301 : 1824.</Citation>
</Reference>
<Reference>
<Citation>Normile D.. Lab accidents prompt calls for new containment program. Science 2004 ; 304 : 1223–1225.</Citation>
</Reference>
<Reference>
<Citation>Henkel RD, Miller T, Weyant RS. Monitoring select agent theft, loss and release reports in the United States-2004–2010. Applied Biosafety 2012.</Citation>
</Reference>
<Reference>
<Citation>Ren W, Qu X, Li W, et al. Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin. JVI 2008 ; 82 : 1899–1907.</Citation>
</Reference>
<Reference>
<Citation>Menachery VD, Dinnon KH, Yount BL, et al. Trypsin treatment unlocks barrier for zoonotic bat coronavirus infection. J Virol 2020; 94 : e01774–19.</Citation>
</Reference>
<Reference>
<Citation>Zeng LP, Gao YT, Ge XY, et al. Bat severe acute respiratory syndrome-like coronavirus WIV1 encodes an extra accessory protein, ORFX, involved in modulation of the host immune response. J Virol 2016 ; 90 : 6573–6582.</Citation>
</Reference>
<Reference>
<Citation>Follis KE, York J, Nunberg JH. Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry. Virology 2006 ; 350 : 358–369.</Citation>
</Reference>
<Reference>
<Citation>Belouzard S, Chu VC, Whittaker GR. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci USA 2009 ; 106 : 5871–5876.</Citation>
</Reference>
<Reference>
<Citation>Thao TTN, Labroussaa F, Ebert N, et al. Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform. Nature 2020; 1–8.</Citation>
</Reference>
<Reference>
<Citation>Coutard B, Valle C, Lamballerie X de, et al. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res 2020; 176 : 104742.</Citation>
</Reference>
<Reference>
<Citation>Moulard M, Decroly E. Maturation of HIV envelope glycoprotein precursors by cellular endoproteases. Biochim Biophys Acta 2000 ; 1469 : 121–132.</Citation>
</Reference>
<Reference>
<Citation>Sun X, Tse LV, Ferguson AD, et al. Modifications to the hemagglutinin cleavage site control the virulence of a neurotropic H1N1 influenza virus. J Virol 2010 ; 84 : 8683–8690.</Citation>
</Reference>
<Reference>
<Citation>Lau SY, Wang P, Mok BWY, et al. Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction. Emerg Microbes Infect 2020; 9 : 837–842.</Citation>
</Reference>
<Reference>
<Citation>Matsuyama S, Shirato K, Kawase M, et al. Middle East respiratory syndrome coronavirus spike protein is not activated directly by cellular furin during viral entry into target cells. J Virol 2018 ; 92 : e00683–e00618.</Citation>
</Reference>
<Reference>
<Citation>Pradhan P, Pandey AK, Mishra A, et al. Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag. BioRxiv 2020; 2020.01.30.927871.</Citation>
</Reference>
<Reference>
<Citation>Shang J, Wan Y, Luo C, et al. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci USA 2020; 117 : 11727–34.</Citation>
</Reference>
<Reference>
<Citation>Hassanin A. The SARS-CoV-2-like virus found in captive pangolins from Guangdong should be better sequenced. BioRxiv 2020; 2020.05.07.077016.</Citation>
</Reference>
<Reference>
<Citation>Gu H, Chu D, Peiris M, et al. Multivariate analyses of codon usage of SARS-CoV-2 and other betacoronaviruses. BioRxiv 2020; 2020.02.15.950568.</Citation>
</Reference>
<Reference>
<Citation>Hua L, Gong S, Wang F, et al. Captive breeding of pangolins: current status, problems and future prospects. Zookeys 2015 ; 99–114.</Citation>
</Reference>
<Reference>
<Citation>Gibbs AJ, Armstrong JS, Downie JC. From where did the 2009 swine-origin influenza A virus (H1N1) emerge?. Virol J 2009 ; 6 : 207.</Citation>
</Reference>
<Reference>
<Citation>NIH. Statement on funding pause on certain types of gain-of-function research. National Institutes of Health (NIH), 2015.</Citation>
</Reference>
<Reference>
<Citation>Burki T.. Ban on gain-of-function studies ends. Lancet Infect Dis 2018 ; 18 : 148–149.</Citation>
</Reference>
<Reference>
<Citation>Iseni F, Tournier JN. Une course contre la montre : création du SARS-CoV-2 en laboratoire, un mois après son émergence ! Med Sci (Paris) 2020; 36 : 797–801.</Citation>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Provence-Alpes-Côte d'Azur</li>
<li>Île-de-France</li>
</region>
<settlement>
<li>Marseille</li>
<li>Paris</li>
</settlement>
</list>
<tree>
<country name="France">
<region name="Île-de-France">
<name sortKey="Sallard, Erwan" sort="Sallard, Erwan" uniqKey="Sallard E" first="Erwan" last="Sallard">Erwan Sallard</name>
</region>
<name sortKey="Casane, Didier" sort="Casane, Didier" uniqKey="Casane D" first="Didier" last="Casane">Didier Casane</name>
<name sortKey="Decroly, Etienne" sort="Decroly, Etienne" uniqKey="Decroly E" first="Étienne" last="Decroly">Étienne Decroly</name>
<name sortKey="Halloy, Jose" sort="Halloy, Jose" uniqKey="Halloy J" first="José" last="Halloy">José Halloy</name>
<name sortKey="Van Helden, Jacques" sort="Van Helden, Jacques" uniqKey="Van Helden J" first="Jacques" last="Van Helden">Jacques Van Helden</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000068 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000068 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32773024
   |texte=   [Tracing the origins of SARS-COV-2 in coronavirus phylogenies].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32773024" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021